| 000 | 01511 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513092455.0 | ||
| 264 | 0 | _c19960821 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/88.15.1039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGelber, R D | |
| 245 | 0 | 0 |
_aA quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cAug 1996 |
||
| 300 |
_a1039-45 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 |
_aRectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGoldhirsch, A | |
| 700 | 1 | _aCole, B F | |
| 700 | 1 | _aWieand, H S | |
| 700 | 1 | _aSchroeder, G | |
| 700 | 1 | _aKrook, J E | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 88 _gno. 15 _gp. 1039-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/88.15.1039 _zAvailable from publisher's website |
| 999 |
_c8681461 _d8681461 |
||